Skip to main content

ADSTILADRIN Early Utilization and Outcomes in the Real World Setting in the United States

Submitted by rachel on Mon, 07/22/2024 - 18:04
  • Read more about ADSTILADRIN Early Utilization and Outcomes in the Real World Setting in the United States

Tobacco Cessation at FDNY

Submitted by rachel on Mon, 07/22/2024 - 18:04
  • Read more about Tobacco Cessation at FDNY

A Phase 1, Study of BMF-500 in Adults With Acute Leukemia

Submitted by rachel on Mon, 07/22/2024 - 18:04
  • Read more about A Phase 1, Study of BMF-500 in Adults With Acute Leukemia

MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions

Submitted by rachel on Mon, 07/22/2024 - 18:04
  • Read more about MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

Submitted by rachel on Mon, 07/22/2024 - 18:04
  • Read more about An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Submitted by rachel on Mon, 07/22/2024 - 18:04
  • Read more about Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

A Study of SNDX-5613 in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia

Submitted by rachel on Mon, 07/22/2024 - 18:04
  • Read more about A Study of SNDX-5613 in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia

An Open-label Study of XEN1101 in Epilepsy

Submitted by rachel on Mon, 07/22/2024 - 18:04
  • Read more about An Open-label Study of XEN1101 in Epilepsy

Hospital Airway Resuscitation Trial

Submitted by rachel on Mon, 07/22/2024 - 18:03
  • Read more about Hospital Airway Resuscitation Trial

A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥50 Years of Age

Submitted by rachel on Mon, 07/22/2024 - 18:03
  • Read more about A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥50 Years of Age

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • Page 24
  • …
  • Next page Next
  • Last page Last
Subscribe to